Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Snape

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Vaccine|March 27, 2018
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UKRobin Marlow, Sherine Kuriyakose, Narcisa Mesaros, et al.
Plos One|June 20, 2015
Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 VaccinationSimon Thebault, Patrick Waters, Matthew D Snape, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2013
Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year laterKatja Hoschler, Nick J Andrews, Saul N Faust, et al.
Science (New York, N.Y.)|July 30, 2021
Preventing type 1 diabetes in childhoodColin M Dayan, Rachel E J Besser, Richard A Oram, et al.
Plos One|March 13, 2014
Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trialJohannes Trück, Matthew D Snape, Florencia Tatangeli, et al.
Archives of Disease in Childhood|March 12, 2013
UK vaccination schedule: persistence of immunity to hepatitis B in children vaccinated after perinatal exposureTom A Yates, Karthikeyan Paranthaman, Ly-Mee Yu, et al.
Vaccine|September 24, 2024
Comparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV)Rajeka Lazarus, Rosie Harris, Russell Thirard, et al.
The Pediatric Infectious Disease Journal|June 8, 2012
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up studyAmeneh Khatami, Matthew D Snape, Jacek Wysocki, et al.
Vaccine|October 28, 2020
Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testingMarta Valente Pinto, Kimberly Davis, Nick Andrews, et al.
Vaccine|April 11, 2017
Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13Johannes Trück, Amber Thompson, Begonia Morales-Aza, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Vaccine|March 27, 2018
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UKRobin Marlow, Sherine Kuriyakose, Narcisa Mesaros, et al.
Plos One|June 20, 2015
Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 VaccinationSimon Thebault, Patrick Waters, Matthew D Snape, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2013
Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year laterKatja Hoschler, Nick J Andrews, Saul N Faust, et al.
Science (New York, N.Y.)|July 30, 2021
Preventing type 1 diabetes in childhoodColin M Dayan, Rachel E J Besser, Richard A Oram, et al.
Plos One|March 13, 2014
Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trialJohannes Trück, Matthew D Snape, Florencia Tatangeli, et al.
Archives of Disease in Childhood|March 12, 2013
UK vaccination schedule: persistence of immunity to hepatitis B in children vaccinated after perinatal exposureTom A Yates, Karthikeyan Paranthaman, Ly-Mee Yu, et al.
Vaccine|September 24, 2024
Comparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV)Rajeka Lazarus, Rosie Harris, Russell Thirard, et al.
The Pediatric Infectious Disease Journal|June 8, 2012
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up studyAmeneh Khatami, Matthew D Snape, Jacek Wysocki, et al.
Vaccine|October 28, 2020
Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testingMarta Valente Pinto, Kimberly Davis, Nick Andrews, et al.
Vaccine|April 11, 2017
Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13Johannes Trück, Amber Thompson, Begonia Morales-Aza, et al.
Pageof 17